JP Patent
JP3145431B2 — 安定同位体標識蛋白質の製造法および試薬キット
Assigned to Nippon Sanso Holdings Corp · Expires 2001-03-12 · 25y expired
What this patent protects
Patent listed against Uptravi.
Drugs covered by this patent
- Uptravi (SELEXIPAG) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.